MORGAN STANLEY - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 114 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,380,045
-33.8%
1,381,718
+3.8%
0.00%
-100.0%
Q2 2023$6,617,242
+36.5%
1,331,437
+35.7%
0.00%0.0%
Q1 2023$4,848,488
-9.4%
981,475
+15.4%
0.00%0.0%
Q4 2022$5,349,513
-19.6%
850,479
+38.1%
0.00%0.0%
Q3 2022$6,653,000
-48.7%
616,019
-45.8%
0.00%
-50.0%
Q2 2022$12,964,000
-15.7%
1,137,265
-32.6%
0.00%0.0%
Q1 2022$15,380,000
-18.6%
1,688,441
+33.4%
0.00%0.0%
Q4 2021$18,890,000
-30.9%
1,266,055
+19.1%
0.00%
-50.0%
Q3 2021$27,319,000
-7.3%
1,063,026
-5.9%
0.00%0.0%
Q2 2021$29,456,000
+792.1%
1,129,478
+1107.0%
0.00%
Q1 2021$3,302,000
-61.8%
93,580
-72.7%
0.00%
-100.0%
Q4 2020$8,651,000
+14.5%
342,782
+71.0%
0.00%0.0%
Q3 2020$7,558,000
+275.1%
200,415
+325.8%
0.00%
Q2 2020$2,015,000
+119.0%
47,070
-0.5%
0.00%
Q1 2020$920,000
-55.9%
47,329
-41.0%
0.00%
Q4 2019$2,084,000
+141.2%
80,166
+153.1%
0.00%
Q3 2019$864,000
+232.3%
31,674
+226.3%
0.00%
Q2 2019$260,0000.0%9,707
+7.7%
0.00%
Q1 2019$260,000
-73.7%
9,016
-75.5%
0.00%
Q4 2018$990,00036,7310.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders